Skip to search formSkip to main contentSkip to account menu

A 437203

Known as: A-437203 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Renoprotective effect of a dopamine D3 receptor antagonist in experimental type II diabetes
Diabetic nephropathy is the leading cause of end-stage renal disease. Dopamine receptors are involved in the regulation of renal… 
2006
2006
Effect of Dopamine D3 Antagonists on PPI in DBA/2J Mice or PPI Deficit Induced by Neonatal Ventral Hippocampal Lesions in Rats
Schizophrenic patients typically exhibit impairment of sensorimotor gating, which can be modeled in animal models such as the… 
Highly Cited
2005
Highly Cited
2005
Antidepressant-Like Effect of D2/3 Receptor-, but not D4 Receptor-Activation in the Rat Forced Swim Test
Dopamine plays a role in the pathophysiology of depression and therapeutic effects of antidepressants but the contribution of… 
2005
2005
Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test.
Dopamine plays a role in the pathophysiology of depression and therapeutic effects of antidepressants but the contribution of… 
Highly Cited
2004
Highly Cited
2004
The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors
AbstractRationaleRecent studies have reported antidepressant-like activities of the dopamine D2/D3 agonist pramipexole in the… 
Highly Cited
2003
Highly Cited
2003
Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)